MEDP Medpace Holdings, Inc. - Common Stock

NASDAQ · Life Sciences Tools & Services · Voir sur SEC EDGAR ↗
$410,59
Prix · Mai 20, 2026
Données fondamentales au Avr 23, 2026

MEDP Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines

Prix
$410.58
Capitalisation Boursière
$15.93B
P/E (TTM)
36.8
BPA (TTM)
$15.28
Revenus (TTM)
$2.53B
Rendement div.
ROE
142.9%
Dette/Capitaux propres
Fourchette 52 semaines
$287 – $629

MEDP Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue

Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA

Revenus et bénéfice net $2.53B
9-point trend, +480.1%
2017-12-31 2025-12-31
BPA $15.28
9-point trend, +1459.2%
2017-12-31 2025-12-31
Flux de trésorerie libre $682M
9-point trend, +696.0%
2017-12-31 2025-12-31
Marges 17.8%

Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?

Métrique
Tendance sur 5 ans
MEDP
Médiane des pairs
P/E (TTM)
5-point trend, -18.8%
36.8
33.3
P/S (TTM)
5-point trend, -8.2%
6.3
5.2
P/B
5-point trend, +322.1%
34.7
6.2
Price / FCF (Cours / FCF)
5-point trend, -29.9%
23.4

Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC

Métrique
Tendance sur 5 ans
MEDP
Médiane des pairs
Operating Margin (Marge d'exploitation)
5-point trend, +21.6%
21.1%
Net Profit Margin (Marge nette)
5-point trend, +12.0%
17.8%
16.2%
ROA
5-point trend, +85.7%
22.1%
10.8%
ROE
5-point trend, +627.2%
142.9%
21.0%
ROIC
5-point trend, +416.1%
96.9%

Santé financière Dette, liquidité, solvabilité — solidité du bilan

Métrique
Tendance sur 5 ans
MEDP
Médiane des pairs
Current Ratio (Ratio de liquidité)
5-point trend, -40.6%
0.7
1.7
Quick Ratio (Ratio de liquidité réduite)
5-point trend, -42.4%
0.7

Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans

Métrique
Tendance sur 5 ans
MEDP
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
5-point trend, +121.5%
20.0%
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
5-point trend, +121.5%
20.1%
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
5-point trend, +121.5%
22.3%
EPS YoY (BPA Année/Année)
5-point trend, +217.7%
21.0%
Net Income YoY (Bénéfice net YoY)
5-point trend, +148.1%
11.6%

Indicateurs par action BPA, valeur comptable par action, flux de trésorerie par action, dividende par action

Métrique
Tendance sur 5 ans
MEDP
Médiane des pairs
EPS (Diluted) (BPA (Dilué))
5-point trend, +217.7%
$15.28

Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances

Métrique
Tendance sur 5 ans
MEDP
Médiane des pairs

MEDP Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse

ACHAT 20 analystes
  • Achat fort 4 20,0%
  • Achat 5 25,0%
  • Conserver 10 50,0%
  • Vente 1 5,0%
  • Vente forte 0 0,0%

Objectif de cours à 12 mois

12 analystes · 2026-05-14
Objectif médian $456.00 +11,1%
Objectif moyen $442.83 +7,9%

Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats

Surprise Moyenne
0.33%
Période EPS Actual BPA est. Surprise
31 mars 2026 $4.28 $3.96 0.32%
31 décembre 2025 $4.67 $4.26 0.41%
30 septembre 2025 $3.86 $3.59 0.27%
30 juin 2025 $3.10 $3.02 0.08%
31 mars 2025 $3.67 $3.11 0.56%

Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur

Ticker Capitalisation Boursière P/E Revenus Année/Année Marge Nette ROE Marge Brute
MEDP $15.93B 36.8 20.0% 17.8% 142.9%
IQV $38.23B 28.8 5.9% 8.3% 21.6%
MTD $28.38B 33.2 4.0% 21.6% -615.5% 59.4%
WST $19.81B 40.5 6.2% 16.1% 16.2% 35.9%
ILMN $20.65B 24.8 -0.66% 19.6% 34.1% 66.1%
TEM -41.9 83.4% -19.3% -61.2%
RVTY $10.86B 46.7 3.7% 8.5% 3.3%
TEM -41.9 83.4% -19.3% -61.2%
BIO
CRL $10.02B -70.0 -0.85% -3.6% -4.4%
TECH $7.97B 111.8 5.2% 6.0% 3.7% 64.8%

Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie

Compte de résultat 13
Données annuelles Compte de résultat pour MEDP
Métrique Tendance 20252024202320222021202020192018201720162015
Revenue 11-point trend, +604.7% $2.53B $2.11B $1.89B $1.46B $1.14B $926M $861M $705M $436M $422M $359M
SG&A Expense 11-point trend, +246.6% $198M $180M $161M $131M $108M $92M $95M $76M $63M $62M $57M
Operating Expenses 11-point trend, +489.5% $2.00B $1.66B $1.55B $1.18B $944M $759M $734M $604M $371M $369M $338M
Operating Income 11-point trend, +2501.6% $535M $447M $337M $279M $199M $167M $127M $101M $65M $52M $21M
Other Non-op 11-point trend, -371.1% $-5M $4M $-655.0K $7M $3M $1M $-863.0K $1M $-354.0K $-423.0K $-1M
Pretax Income 11-point trend, +7026.9% $542M $476M $336M $283M $202M $169M $125M $94M $57M $22M $-8M
Income Tax 11-point trend, +10724.9% $91M $72M $53M $37M $20M $23M $24M $21M $18M $9M $843.0K
Net Income 11-point trend, +5301.5% $451M $404M $283M $245M $182M $145M $100M $73M $39M $13M $-9M
EPS (Basic) 11-point trend, +5685.7% $15.64 $13.06 $9.20 $7.57 $5.06 $4.07 $2.79 $2.05 $1.00 $0.38 $-0.28
EPS (Diluted) 11-point trend, +5557.1% $15.28 $12.63 $8.88 $7.28 $4.81 $3.84 $2.67 $1.97 $0.98 $0.37 $-0.28
Shares (Basic) 11-point trend, -8.0% 28,846,000 30,957,000 30,722,000 32,388,000 35,862,000 35,635,000 35,881,000 35,547,000 39,056,000 35,690,000 31,346,000
Shares (Diluted) 11-point trend, -5.8% 29,527,000 32,014,000 31,841,000 33,671,000 37,697,000 37,708,000 37,576,000 36,912,000 39,839,000 36,329,000 31,346,000
EBITDA 10-point trend, +919.1% $535M $447M $337M $279M $199M $167M $127M $101M $65M $52M ·
Bilan 29
Données annuelles Bilan pour MEDP
Métrique Tendance 20252024202320222021202020192018201720162015
Cash & Equivalents 11-point trend, +3240.4% $497M $669M $245M $28M $461M $278M $132M $23M $26M $37M $15M
Receivables 11-point trend, +517.7% $402M $296M $298M $253M $186M $161M $156M $133M $83M $80M $65M
Prepaid Expense 11-point trend, +660.7% $90M $63M $50M $52M $43M $35M $29M $21M $20M $16M $12M
Current Assets 11-point trend, +944.8% $990M $1.03B $594M $334M $691M $474M $317M $178M $130M $133M $95M
PP&E (Net) 11-point trend, +249.4% $131M $124M $121M $110M $93M $85M $47M $52M $49M $44M $38M
PP&E (Gross) 11-point trend, +427.8% $254M $222M $200M $172M $144M $124M $79M $85M $75M $61M $48M
Accum. Depreciation 11-point trend, +1055.0% $123M $99M $79M $62M $51M $39M $32M $33M $26M $18M $11M
Goodwill 11-point trend, +0.2% $662M $662M $662M $662M $662M $662M $662M $661M $661M $661M $661M
Intangibles 11-point trend, -82.1% $33M $34M $36M $38M $41M $46M $54M $69M $99M $136M $187M
Other Non-current Assets 11-point trend, +458.7% $22M $22M $25M $21M $17M $9M $9M $7M $6M $5M $4M
Total Assets 11-point trend, +100.8% $1.98B $2.10B $1.66B $1.35B $1.66B $1.39B $1.14B $968M $951M $979M $984M
Accounts Payable 11-point trend, +222.4% $28M $33M $32M $33M $26M $27M $22M $17M $17M $11M $9M
Accrued Liabilities 11-point trend, +1930.6% $408M $308M $293M $210M $159M $134M $109M $87M $24M $24M $20M
Short-term Debt 3-point trend, +0.00 · · $0 $50M $0 · · · · · ·
Current Liabilities 11-point trend, +902.7% $1.34B $1.10B $925M $803M $557M $440M $343M $257M $193M $169M $134M
Capital Leases 11-point trend, +275.4% $114M $126M $142M $139M $131M $115M $45M $24M $27M $29M $30M
Deferred Tax 11-point trend, -93.6% $1M $2M $2M $1M $1M $14M $13M $439.0K $560.0K $12M $21M
Other Non-current Liabilities 11-point trend, +690.8% $58M $43M $28M $23M $18M $16M $16M $17M $11M $8M $7M
Total Liabilities 11-point trend, +165.8% $1.52B $1.28B $1.10B $966M $707M $585M $417M $378M $447M $368M $571M
Long-term Debt 4-point trend, -78.9% · · · · · · · $80M $222M $165M $378M
Total Debt 6-point trend, -100.0% · · $0 $50M · · $0 $80M $222M $164M ·
Common Stock 11-point trend, -12.9% $284.0K $306.0K $308.0K $309.0K $360.0K $355.0K $360.0K $356.0K $355.0K $407.0K $326.0K
Paid-in Capital 2-point trend, +42.1% · · · · · · · · · $624M $439M
Retained Earnings 11-point trend, -1899.1% $-460M $8M $-222M $-360M $235M $115M $68M $-41M $-120M $-10M $-23M
Treasury Stock 10-point trend, +12156000.00 $12M $12M $12M $12M $5M $6M $6M $6M $6M $0 ·
AOCI 11-point trend, -91.7% $-5M $-15M $-10M $-12M $-5M $-131.0K $-3M $-3M $-734.0K $-4M $-3M
Stockholders' Equity 11-point trend, +11.0% $459M $826M $559M $386M $953M $806M $726M $599M $509M $611M $413M
Liabilities + Equity 11-point trend, +100.8% $1.98B $2.10B $1.66B $1.35B $1.66B $1.39B $1.14B $968M $951M $979M $984M
Shares Outstanding 11-point trend, -13.0% 28,370,780 30,630,799 30,752,292 31,091,694 36,006,778 35,519,989 36,065,278 35,665,910 35,466,510 40,662,856 32,624,461
Flux de trésorerie 13
Données annuelles Flux de trésorerie pour MEDP
Métrique Tendance 20252024202320222021202020192018201720162015
Stock-based Comp 11-point trend, +55.8% $35M $26M $21M $21M $14M $14M $21M $6M $4M $10M $22M
Deferred Tax 11-point trend, +737.6% $81M $-27M $-25M $-23M $-37M $527.0K $10M $4M $3M $-9M $-13M
Amort. of Intangibles 11-point trend, -98.5% $946.0K $1M $2M $3M $5M $8M $15M $30M $38M $51M $63M
Operating Cash Flow 11-point trend, +730.6% $713M $609M $433M $388M $263M $259M $202M $157M $97M $92M $86M
CapEx 11-point trend, +385.0% $31M $37M $37M $37M $28M $31M $18M $16M $12M $14M $6M
Investing Cash Flow 10-point trend, -132.0% $-31M $-28M $-35M $-39M $-31M $-31M $-19M $-17M $-12M $-13M ·
Stock Issued 4-point trend, -100.0% · · · · · · · $0 $0 $174M $608.0K
Stock Repurchased 11-point trend, +917389000.00 $917M $170M $144M $848M $62M $98M $0 $0 $156M $0 $0
Net Stock Activity 10-point trend, -628.5% $-917M $-170M $-144M $-848M $-62M $-98M $0 $0 $-156M $174M ·
Financing Cash Flow 10-point trend, -1383.2% $-860M $-154M $-183M $-776M $-44M $-82M $-74M $-142M $-98M $-58M ·
Net Change in Cash 11-point trend, -357.8% $-172M $424M $217M $-433M $184M $146M $109M $-3M $-11M $20M $-38M
Taxes Paid 11-point trend, +276.4% $40M $84M $76M $50M $56M $23M $13M $23M $17M $18M $11M
Free Cash Flow 10-point trend, +772.0% $682M $572M $397M $351M $235M $227M $184M $141M $86M $78M ·
Rentabilité 7
Données annuelles Rentabilité pour MEDP
Métrique Tendance 20252024202320222021202020192018201720162015
Operating Margin 10-point trend, +69.8% 21.1% 21.2% 17.9% 19.1% 17.4% 18.0% 14.8% 14.3% 14.9% 12.4% ·
Net Margin 10-point trend, +460.7% 17.8% 19.2% 15.0% 16.8% 15.9% 15.7% 11.7% 10.4% 9.0% 3.2% ·
Pretax Margin 10-point trend, +311.5% 21.4% 22.6% 17.8% 19.4% 17.7% 18.2% 14.5% 13.3% 13.1% 5.2% ·
EBITDA Margin 10-point trend, +69.8% 21.1% 21.2% 17.9% 19.1% 17.4% 18.0% 14.8% 14.3% 14.9% 12.4% ·
ROA 10-point trend, +1515.3% 22.1% 21.5% 18.8% 16.3% 11.9% 11.5% 9.3% 7.6% 4.0% 1.4% ·
ROE 10-point trend, +5353.8% 142.9% 47.4% 54.9% 66.6% 19.7% 18.2% 14.2% 12.7% 7.0% 2.6% ·
ROIC 10-point trend, +2241.1% 96.9% 46.0% 50.8% 55.4% 18.8% 17.9% 14.1% 11.8% 6.1% 4.1% ·
Liquidité et Solvabilité 4
Données annuelles Liquidité et Solvabilité pour MEDP
Métrique Tendance 20252024202320222021202020192018201720162015
Current Ratio 10-point trend, -6.8% 0.7 0.9 0.6 0.4 1.2 1.1 0.9 0.7 0.7 0.8 ·
Quick Ratio 10-point trend, -3.5% 0.7 0.9 0.6 0.4 1.2 1.0 0.8 0.6 0.6 0.7 ·
Debt / Equity 6-point trend, -100.0% · · 0.0 0.1 · · 0.0 0.1 0.4 0.3 ·
LT Debt / Equity 4-point trend, -100.0% · · · · · · 0.0 0.1 0.4 0.2 ·
Efficacité 2
Données annuelles Efficacité pour MEDP
Métrique Tendance 20252024202320222021202020192018201720162015
Asset Turnover 10-point trend, +189.0% 1.2 1.1 1.3 1.0 0.7 0.7 0.8 0.7 0.5 0.4 ·
Receivables Turnover 10-point trend, +24.5% 7.2 7.1 6.8 6.6 6.6 5.8 6.0 6.5 5.4 5.8 ·
Par action 5
Données annuelles Par action pour MEDP
Métrique Tendance 20252024202320222021202020192018201720162015
Book Value / Share 10-point trend, +7.7% $16.18 $26.95 $18.18 $12.43 $26.47 $22.69 $20.14 $16.53 $14.20 $15.02 ·
Revenue / Share 10-point trend, +638.4% $85.69 $65.88 $59.23 $43.36 $30.30 $24.56 $22.91 $19.09 $10.95 $11.60 ·
Cash Flow / Share 10-point trend, +856.6% $24.15 $19.02 $13.61 $11.52 $6.99 $6.86 $5.37 $4.24 $2.44 $2.52 ·
Cash / Share 10-point trend, +1820.2% $17.52 $21.86 $7.98 $0.91 $12.81 $7.82 $3.66 $0.65 $0.75 $0.91 ·
EPS (TTM) 10-point trend, +4029.7% $15.28 $12.63 $8.88 $7.28 $4.81 $3.84 $2.67 $1.97 $0.98 $0.37 ·
Taux de croissance 9
Données annuelles Taux de croissance pour MEDP
Métrique Tendance 20252024202320222021202020192018201720162015
Revenue YoY 5-point trend, -14.6% 20.0% 11.8% 29.2% 27.8% 23.4% · · · · · ·
Revenue CAGR 3Y 3-point trend, -24.8% 20.1% 22.7% 26.8% · · · · · · · ·
Revenue CAGR 5Y 22.3% · · · · · · · · · ·
EPS YoY 5-point trend, -16.9% 21.0% 42.2% 22.0% 51.3% 25.3% · · · · · ·
EPS CAGR 3Y 3-point trend, -13.0% 28.0% 38.0% 32.2% · · · · · · · ·
EPS CAGR 5Y 31.8% · · · · · · · · · ·
Net Income YoY 5-point trend, -53.9% 11.6% 43.0% 15.3% 34.9% 25.1% · · · · · ·
Net Income CAGR 3Y 3-point trend, -9.3% 22.5% 30.5% 24.8% · · · · · · · ·
Net Income CAGR 5Y 25.4% · · · · · · · · · ·
Valorisation (TTM) 14
Données annuelles Valorisation (TTM) pour MEDP
Métrique Tendance 20252024202320222021202020192018201720162015
Revenue TTM 10-point trend, +500.2% $2.53B $2.11B $1.89B $1.46B $1.14B $926M $861M $705M $436M $422M ·
Net Income TTM 10-point trend, +3260.3% $451M $404M $283M $245M $182M $145M $100M $73M $39M $13M ·
Market Cap 10-point trend, +986.4% $15.93B $10.18B $9.43B $6.60B $7.84B $4.94B $3.03B $1.89B $1.29B $1.47B ·
Enterprise Value 6-point trend, +476.2% · · $9.18B $6.63B · · $2.90B $1.94B $1.48B $1.59B ·
P/E 10-point trend, -62.3% 36.8 26.3 34.5 29.2 45.2 36.2 31.5 26.9 37.0 97.5 ·
P/S 10-point trend, +81.0% 6.3 4.8 5.0 4.5 6.9 5.3 3.5 2.7 2.9 3.5 ·
P/B 10-point trend, +1345.3% 34.7 12.3 16.9 17.1 8.2 6.1 4.2 3.2 2.6 2.4 ·
P / Tangible Book 3-point trend, +54.9% · 79.0 · · 31.5 51.0 · · · · ·
P / Cash Flow 10-point trend, +39.7% 22.3 16.7 21.8 17.0 29.8 19.1 15.0 12.1 13.2 16.0 ·
P / FCF 10-point trend, +24.6% 23.4 17.8 23.8 18.8 33.3 21.7 16.5 13.4 15.0 18.8 ·
EV / EBITDA 6-point trend, -10.2% · · 27.3 23.8 · · 22.8 19.2 22.8 30.4 ·
EV / FCF 6-point trend, +13.6% · · 23.1 18.9 · · 15.8 13.8 17.3 20.4 ·
EV / Revenue 6-point trend, +28.8% · · 4.9 4.5 · · 3.4 2.8 3.4 3.8 ·
Earnings Yield 10-point trend, +164.1% 2.7% 3.8% 2.9% 3.4% 2.2% 2.8% 3.2% 3.7% 2.7% 1.0% ·

États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années

Compte de résultat
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenu $2.53B$2.11B$1.89B$1.46B$1.14B
Marge d'exploitation % 21.1%21.2%17.9%19.1%17.4%
Résultat net $451M$404M$283M$245M$182M
BPA dilué $15.28$12.63$8.88$7.28$4.81
Bilan
2025-12-312024-12-312023-12-312022-12-312021-12-31
Dette / Capitaux propres 0.00.1
Ratio de liquidité 0.70.90.60.41.2
Ratio de liquidité réduite 0.70.90.60.41.2
Flux de trésorerie
2025-12-312024-12-312023-12-312022-12-312021-12-31
Flux de trésorerie libre $682M$572M$397M$351M$235M

Dernières actualités Actualités récentes mentionnant cette entreprise

Signaux de trading Signaux d'achat/vente récents avec prix d'entrée et ratio risque/récompense

Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets

📊

Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.

Votre sélection est enregistrée et vous suit sur tous les tickers.